A patentee is entitled to damages that are "adequate to compensate for the infringement." This statutory mandate provides a two-part analysis: first, assessing what constitutes infringement.
Specialty Generics Market Set for Robust Growth with an 8.7% CAGR Through 2032 pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
Vanda's Hetlioz Faces Dipping Revenue and FDA Challenges in Q1 sleepreviewmag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sleepreviewmag.com Daily Mail and Mail on Sunday newspapers.
WASHINGTON, April 22, 2024 /PRNewswire/ Vanda Pharmaceuticals Inc. today announced that the Supreme Court denied Vanda s petition for a writ of certiorari in its HETLIOZ® Abbreviated New Drug.